South Africa has the world’s highest AIDS burden.
Most of the reasons people don’t take their medication aren't related to the antiretrovirals themselves, but rather social and systemic issues.
New HIV infections continue to drive the epidemic.
Until then we need to get effective, accessible treatment for all who need it, while deploying the many prevention tools at our disposal.
A community health worker interacting with children in a village South Africa’s Limpopo province.
Anova Health Institute
Community-based HIV programmes helps improve access to health care.
The largest number of HIV-exposed but uninfected children are in South Africa.
HIV negative children born to women with HIV have a greater risk of dying before their first birthday.
More than a year after a groundbreaking liver transplant doctors still can’t say if the recipient is HIV-positive or not.
A liver transplant from an HIV-positive living donor to an HIV-negative recipient is possible, but there are still gaps in our knowledge.
The first global comparison of adolescents that acquired HIV as newborns highlights the challenges around treatment.
A community health worker conducting a HIV test in a mobile clinic in a remote part of KwaZulu-Natal.
Greg Lomas / Médecins Sans Frontières
Women and children remain the focus of HIV while men are disadvantaged in accessing testing and treatment in Africa.
In rural areas where there are often fewer healthcare professionals available, traditional healers can have a role to play in promoting HIV treatment.
Three new HIV vaccine concepts which rely on high-tech designer proteins are being trialled to see if they can stop the virus.
There are several challenges that South Africa needs to address to bring HIV under control.
South Africa has made tremendous progress towards meeting the 90-90-90 targets but there are some challenges preventing it from reaching the goals set by UNAIDS.
A 3D depiction of HIV which attacks T-cells in the body.
A South African child, who has been in HIV remission for nearly nine years, could help researchers understand how to make remission possible for millions of other HIV positive people.
In the Democratic Republic of Congo, HIV is still highly stigmatised.
HIV remains a synonym for death in Kinshasa and many leave testing and treatment until it's too late. It's not common knowledge that an infected person can live a normal and healthy life.
A young woman performs at an HIV prevention campaign during the International Aids Conference 2016.
International AIDS Society/Abhi Indrarajan
Stemming high HIV rates among adolescent girls and young women in sub-Saharan Africa has become a challenge due to the cycle of transmission.
A client receives HIV/AIDS counseling at a women and children’s hospital in Nigeria. These facilities are not always available in rural areas.
Flickr/ Karen Kasmauski/MCSP
Effectively decentralising HIV and AIDS treatment services helps to improve universal health care. But in Nigeria this approach comes with many challenges.
This human T cell (blue) is under attack by HIV (yellow), the virus that causes AIDS. T cells play a critical role in the body’s immune response.
Seth Pincus, Elizabeth Fischer and Austin Athman, National Institute of Allergy and Infectious Diseases, National Institutes of Health
HIV research continues to search for a cure. The focus is on developing therapies to cure HIV infection or allow people with HIV to safely stop antiretroviral therapy and keep the virus under control.
South African HIV rights group, the Treatment Action Campaign, marching through Durban, calling for antiretroviral access for all.
International AIDS Society/Rogan Ward
Current epidemiological and financial trends suggest there's a major risk of a substantial shortfall in the funds required to sustain life-saving antiretroviral programmes.
The 90-90-90 strategy is an attempt to get the HIV epidemic under control by adopting a ‘test and treat’ approach. This is part of the plan to eliminate AIDS by 2030.
Mental health problems need to be addressed to control the HIV epidemic, but such treatment is not yet part of the HIV care package in sub-Saharan Africa.